Ensemble-plus Study Design: An Investigation of Shortened Ocrelizumab Infusion Time on Infusion-related Reactions in Patients with Relapsing Multiple Sclerosis from the Phase Iiib Ensemble-plus Study

B. Yamout, B. Brochet, C. Nos, M. S. Freedman, J. Killstein, J. Overell, R. Buffels, K. Fitovski, L. Mehta, Q. Wang, H. Hartung